Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[Optic neuritis--immunological approach to elucidate pathogenesis and develop innovative therapy].
AMP-Activated Protein Kinase Signaling Protects Oligodendrocytes that Restore Central Nervous System Functions in an Experimental Autoimmune Encephalomyelitis Model.
In vivo evidence of hippocampal dentate gyrus expansion in multiple sclerosis.
DNA Damage, DNA Repair, Aging, and Neurodegeneration.
Migration of the Fatigue Symptoms and Impacts Questionnaire-Relapsing Multiple Sclerosis (Fsiq-Rms(tm)) from Paper to an Electronic Diary Format.
Pertussis toxin promotes relapsing-remitting experimental autoimmune encephalomyelitis in Lewis rats.
Neutralizing IL-17 protects the optic nerve from autoimmune pathology and prevents retinal nerve fiber layer atrophy during experimental autoimmune encephalomyelitis.
Dietary Sutherlandia and Elderberry Mitigate Cerebral Ischemia-Induced Neuronal Damage and Attenuate p47phox and Phospho-ERK1/2 Expression in Microglial Cells.
The best basic science paper in multiple sclerosis in 2013: Disease specific molecular events in cortical multiple sclerosis lesions.
The role of fractalkine (CX3CL1) in regulation of CD4(+) cell migration to the central nervous system in patients with relapsing-remitting multiple sclerosis.
Mature oligodendrocytes actively increase in vivo cytoskeletal plasticity following CNS damage.
Combined therapy with methylprednisolone and ulinastatin in experimental autoimmune encephalomyelitis.
Understanding the neurobiology of CD200 and the CD200 receptor: a therapeutic target for controlling inflammation in human brains?
PGE2/EP4 signaling in peripheral immune cells promotes development of experimental autoimmune encephalomyelitis.
Chronic cerebrospinal venous insufficiency and multiple sclerosis: a comprehensive meta-analysis of case-control studies.
NQO1 gene rs1800566 variant is not associated with risk for multiple sclerosis.
Inhibition of hydroxymethylglutaryl-coenzyme a reductase reduces Th1 development and promotes Th2 development.
The First Sphingosine 1-Phosphate Lyase Inhibitors against Multiple Sclerosis: A Successful Drug Discovery Tale.
Optimal design of clinical trials with biologics using dose-time-response models.
Implicit memory in multiple sclerosis.
Insights into multiple sclerosis provided by non-coding RNAs: meeting summary from the symposium 'Non-coding RNAs in autoimmune disorders of the central nervous system' on 5 April 2013 in Warsaw, Poland.
No evidence of association between mutant alleles of the CYP27B1 gene and multiple sclerosis.
Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patients.
Silent, invisible and unacknowledged: experiences of young caregivers of single parents diagnosed with multiple sclerosis.
Increased incidence of multiple sclerosis in the Veneto region, Italy.

Pages